321 related articles for article (PubMed ID: 31926377)
21. Cyclometalated Iridium(III) Complexes as High-Sensitivity Two-Photon Excited Mitochondria Dyes and Near-Infrared Photodynamic Therapy Agents.
Bi XD; Yang R; Zhou YC; Chen D; Li GK; Guo YX; Wang MF; Liu D; Gao F
Inorg Chem; 2020 Oct; 59(20):14920-14931. PubMed ID: 32951429
[TBL] [Abstract][Full Text] [Related]
22. Trifluoromethyl-Substituted Iridium(III) Complexes: From Photophysics to Photooxidation of a Biological Target.
Bevernaegie R; Marcélis L; Laramée-Milette B; De Winter J; Robeyns K; Gerbaux P; Hanan GS; Elias B
Inorg Chem; 2018 Feb; 57(3):1356-1367. PubMed ID: 29336560
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of pH-responsive cyclometalated iridium(III) complex and its application in the selective killing of cancerous cells.
Yang P; Zhang S; Wang K; Qi H
Dalton Trans; 2021 Nov; 50(46):17338-17345. PubMed ID: 34788356
[TBL] [Abstract][Full Text] [Related]
24. A Mitochondria-Targeted Photosensitizer Showing Improved Photodynamic Therapy Effects Under Hypoxia.
Lv W; Zhang Z; Zhang KY; Yang H; Liu S; Xu A; Guo S; Zhao Q; Huang W
Angew Chem Int Ed Engl; 2016 Aug; 55(34):9947-51. PubMed ID: 27381490
[TBL] [Abstract][Full Text] [Related]
25. Anticancer Cyclometalated Iridium(III) Complexes with Planar Ligands: Mitochondrial DNA Damage and Metabolism Disturbance.
Cao JJ; Zheng Y; Wu XW; Tan CP; Chen MH; Wu N; Ji LN; Mao ZW
J Med Chem; 2019 Apr; 62(7):3311-3322. PubMed ID: 30816710
[TBL] [Abstract][Full Text] [Related]
26. In Vitro and In Vivo of Triphenylamine-Appended Fluorescent Half-Sandwich Iridium(III) Thiosemicarbazones Antitumor Complexes.
Shao M; Yao M; Liu X; Gao C; Liu W; Guo J; Zong J; Sun X; Liu Z
Inorg Chem; 2021 Nov; 60(22):17063-17073. PubMed ID: 34709784
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, characterization and anticancer activity in vitro and in vivo evaluation of an iridium (III) polypyridyl complex.
Yi QY; Wan D; Tang B; Wang YJ; Zhang WY; Du F; He M; Liu YJ
Eur J Med Chem; 2018 Feb; 145():338-349. PubMed ID: 29331805
[TBL] [Abstract][Full Text] [Related]
28. Tracking mitochondrial dynamics during apoptosis with phosphorescent fluorinated iridium(iii) complexes.
Zhang C; Qiu K; Liu C; Huang H; Rees TW; Ji L; Zhang Q; Chao H
Dalton Trans; 2018 Oct; 47(37):12907-12913. PubMed ID: 30117504
[TBL] [Abstract][Full Text] [Related]
29. A mitochondria-targeting dinuclear Ir-Ru complex as a synergistic photoactivated chemotherapy and photodynamic therapy agent against cisplatin-resistant tumour cells.
Zhang C; Guan R; Liao X; Ouyang C; Rees TW; Liu J; Chen Y; Ji L; Chao H
Chem Commun (Camb); 2019 Oct; 55(83):12547-12550. PubMed ID: 31576841
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of anticancer effect in vitro and in vivo of iridium(III) complexes on gastric carcinoma SGC-7901 cells.
Zhang WY; Wang YJ; Du F; He M; Gu YY; Bai L; Yang LL; Liu YJ
Eur J Med Chem; 2019 Sep; 178():401-416. PubMed ID: 31202128
[TBL] [Abstract][Full Text] [Related]
31. X-ray tomography of cryopreserved human prostate cancer cells: mitochondrial targeting by an organoiridium photosensitiser.
Bolitho EM; Sanchez-Cano C; Huang H; Hands-Portman I; Spink M; Quinn PD; Harkiolaki M; Sadler PJ
J Biol Inorg Chem; 2020 Mar; 25(2):295-303. PubMed ID: 32124100
[TBL] [Abstract][Full Text] [Related]
32. Near-infrared-emitting heteroleptic cationic iridium complexes derived from 2,3-diphenylbenzo[g]quinoxaline as in vitro theranostic photodynamic therapy agents.
Wang L; Yin H; Cui P; Hetu M; Wang C; Monro S; Schaller RD; Cameron CG; Liu B; Kilina S; McFarland SA; Sun W
Dalton Trans; 2017 Jun; 46(25):8091-8103. PubMed ID: 28604869
[TBL] [Abstract][Full Text] [Related]
33. Half-sandwich Iridium
Han Y; Tian Z; Zhang S; Liu X; Li J; Li Y; Liu Y; Gao M; Liu Z
J Inorg Biochem; 2018 Dec; 189():163-171. PubMed ID: 30268969
[TBL] [Abstract][Full Text] [Related]
34. Studies of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes-loaded liposomes as drug delivery system.
Zhang WY; Du F; He M; Bai L; Gu YY; Yang LL; Liu YJ
Eur J Med Chem; 2019 Sep; 178():390-400. PubMed ID: 31202127
[TBL] [Abstract][Full Text] [Related]
35. Amphiphilic Gemini Iridium(III) Complex as a Mitochondria-Targeted Theranostic Agent for Tumor Imaging and Photodynamic Therapy.
Yi S; Lu Z; Zhang J; Wang J; Xie Z; Hou L
ACS Appl Mater Interfaces; 2019 May; 11(17):15276-15289. PubMed ID: 30968687
[TBL] [Abstract][Full Text] [Related]
36. Mitochondria-targeted cyclometalated iridium (III) complexes: Dual induction of A549 cells apoptosis and autophagy.
Chen L; Tang H; Chen W; Wang J; Zhang S; Gao J; Chen Y; Zhu X; Huang Z; Chen J
J Inorg Biochem; 2023 Dec; 249():112397. PubMed ID: 37844533
[TBL] [Abstract][Full Text] [Related]
37. Antitumor properties and mechanisms of mitochondria-targeted Ag(I) and Au(I) complexes containing N-heterocyclic carbenes derived from cyclophanes.
Li Y; Liu GF; Tan CP; Ji LN; Mao ZW
Metallomics; 2014 Aug; 6(8):1460-8. PubMed ID: 24788133
[TBL] [Abstract][Full Text] [Related]
38. Enhancing the tumor cell selectivity of a rhodamine-decorated iridium(III) complex by conjugating with indomethacin for COX-2 targeted photodynamic therapy.
Liu C; Xiang J; Xiang C; Li H
Bioorg Chem; 2021 Sep; 114():105142. PubMed ID: 34243072
[TBL] [Abstract][Full Text] [Related]
39. Ester-Modified Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents.
Wang FX; Chen MH; Hu XY; Ye RR; Tan CP; Ji LN; Mao ZW
Sci Rep; 2016 Dec; 6():38954. PubMed ID: 27958338
[TBL] [Abstract][Full Text] [Related]
40. Valproic Acid-Functionalized Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents.
Ye RR; Cao JJ; Tan CP; Ji LN; Mao ZW
Chemistry; 2017 Oct; 23(60):15166-15176. PubMed ID: 28833658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
